MENU

CTNM Contineum Therapeutics Forecast, Technical & Fundamental Analysis

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions... Show more

CTNM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CTNM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CTNM is expected to report earnings to rise 10.26% to -43 cents per share on November 11

Contineum Therapeutics CTNM Stock Earnings Reports
Q3'26
Est.
$-0.43
Q1'26
Beat
by $0.46
Q4'25
Beat
by $0.16
Q3'25
Beat
by $0.15
Q2'25
Missed
by $0.34
The last earnings report on May 05 showed earnings per share of -38 cents, beating the estimate of -85 cents. With 75.40K shares outstanding, the current market capitalization sits at 557.17M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3565 General Atomics Court
Phone
+1 858 333-5280
Employees
51
Web
https://www.contineum-tx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSSYX27.920.08
+0.29%
Columbia Select Small Cap Value Inst3
PBQAX27.72N/A
N/A
PGIM Jennison Blend A
TMCIX15.59N/A
N/A
RBC SMID Cap Growth I
JABAX49.52N/A
N/A
Janus Henderson Balanced T
JVTSX86.29N/A
N/A
Janus Henderson Venture S

CTNM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with PMN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+1.09%
PMN - CTNM
34%
Loosely correlated
+1.19%
LKFT - CTNM
33%
Loosely correlated
N/A
SLDB - CTNM
33%
Loosely correlated
-4.08%
ZURA - CTNM
31%
Poorly correlated
-3.16%
CADL - CTNM
31%
Poorly correlated
-6.93%
More
Contineum Therapeutics (CTNM) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com